Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-44.77	7.48	13.55
Graham Fair Price	41.42	1.71	1.21
PEG	-81.43	0.04	-0.20
Price/Book	-2.36	0.79	0.81
Price/Cash Flow	-52.18	19.91	41.65
Prices/Earnings	-51.18	3.72	7.62
Price/Sales	-51.18	1.14	2.34
Price/FCF	-52.18	19.91	41.65
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-0.33	0.35	0.35
Operating Margin	-1.48	0.10	0.10
ROA	100.00	0.04	0.02
ROE	0.03	0.05	100.00
ROIC	0.03	0.05	96.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.04	-0.52	-92.87
Dividends QOQ	-0.82	< 0.005	-100.00
EBIT QOQ	0.29	0.97	230.14
EPS QOQ	-0.38	1.00	162.90
FCF QOQ	1.49	1.04	-30.03
Revenue QOQ	-0.37	1.00	168.72
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	31.15	15.55	-50.09
Days Sales Outstanding (DSO)	50.82	25.72	-49.38
Inventory Turnover	2.89	5.79	100.36
Debt/Capitalization	0.06	0.06	3.48
Quick Ratio	1.57	1.38	-12.52
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.57	1.57	< 0.005
Cash	0.40	0.31	-23.05
Capex	-0.03	-0.07	-103.78
Free Cash Flow	0.03	0.06	104.18
Revenue	0.54	1.09	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.85	1.85	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.67	-0.19	92.75
Naive Interpretation	Member

06 - Financial Health · Weak

Rating